Drug intelligence / Profile preview

Arthoven

Development stage: Unknown
Lead developer: AVN Ayurveda Formulations
Administration: Oral

Overview

Arthoven is a polyherbal Ayurvedic formulation developed by AVN Ayurveda Formulations for the management of various autoimmune and musculoskeletal inflammatory disorders. The formulation is a combination of the traditional Ayurvedic decoction Amavatari kashayam and Guggulu (Commiphora mukul). It contains concentrated aqueous extracts from several medicinal plants, including Tinospora cordifolia (Guduchi), Asteracantha longifolia (Kokilaksha), Boerhaavia diffusa (Punarnava), and the Dashamoola complex (a group of ten roots). Arthoven acts as a safe anti-inflammatory and immunomodulator, providing anti-edematous effects and protecting against cartilage degeneration. It is primarily indicated for the long-term management of rheumatoid arthritis, osteoarthritis, gout, ankylosing spondylitis, and synovitis.

Brand names: Arthoven
Other names: Arthoven Tablets

Beyond the preview

Go deeper on Arthoven.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arthoven.